GDRX
GoodRx Holdings, Inc.
Price Chart
Latest Quote
$2.67
+0.10 (+3.89%)
Current Price
| Previous Close | $2.57 |
| Open | $2.51 |
| Day High | $2.67 |
| Day Low | $2.50 |
| Volume | 707,588 |
Stock Information
| Shares Outstanding | 104.71M |
| Total Debt | $541.35M |
| Cash Equivalents | $235.71M |
| Revenue | $787.89M |
| Net Income | $20.56M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $904.26M |
| P/E Ratio | 44.50 |
| EPS (TTM) | $0.06 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.18B |
| Sales | $787.89M |
| Income | $20.56M |
| Book/sh | $1.84 |
| Cash/sh | $2.25 |
| Employees | 697 |
Financial Ratios
| Quick Ratio | 0.56 |
| Current Ratio | 1.47 |
| Debt/Eq | 87.04 |
| EPS Growth TTM | -89.40% |
Returns & Margins
| ROA | 3.48% |
| ROE | 3.22% |
| Gross Margin | 91.83% |
| Operating Margin | 7.22% |
| Profit Margin | 2.61% |
Ownership
| Insider Ownership | 13.64% |
| Institutional Ownership | 56.62% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 7.45 |
| P/S | 1.15 |
| P/B | 1.45 |
Analyst Data
| Recommendation | hold |
| Target Price | $3.18 |
Technical Indicators
| SMA20 | $2.75 |
| SMA50 | $2.58 |
| SMA200 | $2.85 |
| RSI | 36.54 |
| ATR | 0.1464 |
| Shares Float | 91.89M |
| Short Float | 7.73% |
| Short Ratio | 3.76 |
| Volatility | 1.61 |
| Rel Volume | 0.44 |
Performance History
| Week | -2.20% |
| Month | +4.30% |
| Quarter | +28.37% |
| 6 Months | -2.55% |
| YTD | -2.91% |
| Year | -41.96% |
| 3 Years | -53.81% |
| 5 Years | -92.87% |
| 10 Years | -94.71% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $2.67 | 707,588 |
| 2026-06-22 | $2.57 | 1,869,500 |
| 2026-06-18 | $2.66 | 2,098,000 |
| 2026-06-17 | $2.61 | 1,084,900 |
| 2026-06-16 | $2.73 | 1,389,400 |
| 2026-06-15 | $2.73 | 1,163,900 |
| 2026-06-12 | $2.65 | 673,700 |
| 2026-06-11 | $2.63 | 1,077,800 |
| 2026-06-10 | $2.56 | 1,122,300 |
| 2026-06-09 | $2.65 | 1,578,100 |
| 2026-06-08 | $2.63 | 761,300 |
| 2026-06-05 | $2.65 | 2,116,500 |
| 2026-06-04 | $2.85 | 1,339,600 |
| 2026-06-03 | $2.81 | 1,714,400 |
| 2026-06-02 | $2.95 | 1,446,900 |
| 2026-06-01 | $3.08 | 2,465,600 |
| 2026-05-29 | $2.92 | 1,988,900 |
| 2026-05-28 | $2.97 | 2,370,400 |
| 2026-05-27 | $2.86 | 2,015,000 |
| 2026-05-26 | $2.78 | 3,240,900 |
About GoodRx Holdings, Inc.
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
đ° Latest News
Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains?
Zacks âĸ 2026-06-19T08:27:00Z
Q1 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks
StockStory âĸ 2026-06-17T21:47:04Z
1 Stock Under $10 to Target This Week and 2 We Find Risky
StockStory âĸ 2026-06-12T13:01:20Z
Billionaire Mark Cuban Says Americaâs Drug Pricing System Makes Patients Pay the Highest Price, âMake It Make Sense. It Doesnât.â
Barchart âĸ 2026-06-09T16:07:59Z
GoodRx Holdings, Inc. (GDRX) Strengthens Recurring Revenue Base with Companion
Insider Monkey âĸ 2026-06-07T17:59:29Z
1 Small-Cap Stock with Competitive Advantages and 2 We Ignore
StockStory âĸ 2026-06-05T19:04:14Z
3 Penny Stocks With Market Caps Over $100M To Watch
Simply Wall St. âĸ 2026-06-03T12:05:01Z
How The Shifting Story For GoodRx (GDRX) Is Reshaping Analyst Views And Valuation
Simply Wall St. âĸ 2026-05-28T06:06:24Z
3 Reasons Retirees Should Reconsider Enrolling in a Standalone Medicare Drug Plan in 2026
24/7 Wall St. âĸ 2026-05-26T13:39:16Z
3 Value Stocks That Fall Short
StockStory âĸ 2026-05-19T03:16:55Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $57,597,000 | $48,215,000 | $66,925,000 | $65,079,000 |
| Cost Of Revenue | $57,597,000 | $48,215,000 | $66,925,000 | $65,079,000 |
| Total Revenue | $796,853,000 | $792,324,000 | $750,265,000 | $766,554,000 |
| Operating Revenue | $779,167,000 | $771,322,000 | $730,213,000 | $746,128,000 |
| Expenses | ||||
| Interest Expense | $42,605,000 | $52,922,000 | $56,728,000 | $34,243,000 |
| Total Expenses | $709,361,000 | $726,478,000 | $777,272,000 | $764,816,000 |
| Other Income Expense | $718,000 | $-4,737,000 | $-4,008,000 | - |
| Other Non Operating Income Expenses | $718,000 | $-2,660,000 | $-4,008,000 | - |
| Net Non Operating Interest Income Expense | $-31,672,000 | $-29,649,000 | $-24,557,000 | $-24,969,000 |
| Interest Expense Non Operating | $42,605,000 | $52,922,000 | $56,728,000 | $34,243,000 |
| Operating Expense | $651,764,000 | $678,263,000 | $710,347,000 | $699,737,000 |
| Selling And Marketing Expense | $331,560,000 | $367,114,000 | $341,328,000 | $357,631,000 |
| General And Administrative Expense | $113,960,000 | $117,862,000 | $125,515,000 | $144,792,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $30,439,000 | $16,390,000 | $-8,868,000 | $-32,828,000 |
| Net Interest Income | $-31,672,000 | $-29,649,000 | $-24,557,000 | $-24,969,000 |
| Interest Income | $10,933,000 | $23,273,000 | $32,171,000 | $9,274,000 |
| Normalized Income | $30,439,000 | $18,030,830 | $-8,868,000 | $-32,828,000 |
| Net Income From Continuing And Discontinued Operation | $30,439,000 | $16,390,000 | $-8,868,000 | $-32,828,000 |
| Total Operating Income As Reported | $87,492,000 | $65,846,000 | $-27,007,000 | $1,738,000 |
| Net Income Common Stockholders | $30,439,000 | $16,390,000 | $-8,868,000 | $-32,828,000 |
| Net Income | $30,439,000 | $16,390,000 | $-8,868,000 | $-32,828,000 |
| Net Income Including Noncontrolling Interests | $30,439,000 | $16,390,000 | $-8,868,000 | $-32,828,000 |
| Net Income Continuous Operations | $30,439,000 | $16,390,000 | $-8,868,000 | $-32,828,000 |
| Pretax Income | $56,538,000 | $31,460,000 | $-55,572,000 | $-23,231,000 |
| Special Income Charges | $0 | $-2,077,000 | $0 | $0 |
| Interest Income Non Operating | $10,933,000 | $23,273,000 | $32,171,000 | $9,274,000 |
| Operating Income | $87,492,000 | $65,846,000 | $-27,007,000 | $1,738,000 |
| Depreciation Amortization Depletion Income Statement | $85,218,000 | $69,538,000 | $107,668,000 | $54,177,000 |
| Depreciation And Amortization In Income Statement | $85,218,000 | $69,538,000 | $107,668,000 | $54,177,000 |
| Gross Profit | $739,256,000 | $744,109,000 | $683,340,000 | $701,475,000 |
| Average Dilution Earnings | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $0.09 | $0.04 | $-0.02 | $-0.08 |
| Basic EPS | $0.09 | $0.04 | $-0.02 | $-0.08 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-436,170 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $184,361,000 | $155,997,000 | $108,824,000 | $65,189,000 |
| Total Unusual Items | $0 | $-2,077,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $0 | $-2,077,000 | $0 | $0 |
| Reconciled Depreciation | $85,218,000 | $69,538,000 | $107,668,000 | $54,177,000 |
| EBITDA (Bullshit earnings) | $184,361,000 | $153,920,000 | $108,824,000 | $65,189,000 |
| EBIT | $99,143,000 | $84,382,000 | $1,156,000 | $11,012,000 |
| Diluted Average Shares | $356,973,000 | $392,172,000 | $410,315,000 | $412,858,000 |
| Basic Average Shares | $356,327,000 | $385,737,000 | $410,315,000 | $412,858,000 |
| Diluted NI Availto Com Stockholders | $30,439,000 | $16,390,000 | $-8,868,000 | $-32,828,000 |
| Tax Provision | $26,099,000 | $15,070,000 | $-46,704,000 | $9,597,000 |
| Research And Development | $121,026,000 | $123,749,000 | $135,836,000 | $143,137,000 |
| Selling General And Administration | $445,520,000 | $484,976,000 | $466,843,000 | $502,423,000 |
| Other Gand A | $113,960,000 | $117,862,000 | $125,515,000 | $144,792,000 |
| Other Special Charges | - | $2,077,000 | - | - |
| Otherunder Preferred Stock Dividend | - | - | - | $0 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-17,412,000 | $137,006,000 | $194,852,000 | $212,773,000 |
| Total Assets | $1,404,058,000 | $1,388,067,000 | $1,588,800,000 | $1,604,631,000 |
| Total Non Current Assets | $760,956,000 | $728,812,000 | $716,010,000 | $684,945,000 |
| Other Non Current Assets | $29,095,000 | $23,520,000 | $37,775,000 | $27,165,000 |
| Non Current Deferred Assets | $57,111,000 | $77,182,000 | $65,268,000 | $0 |
| Non Current Deferred Taxes Assets | $57,111,000 | $77,182,000 | $65,268,000 | $0 |
| Goodwill And Other Intangible Assets | $633,674,000 | $587,652,000 | $567,106,000 | $602,054,000 |
| Other Intangible Assets | $203,343,000 | $176,883,000 | $156,337,000 | $189,937,000 |
| Current Assets | $643,102,000 | $659,255,000 | $872,790,000 | $919,686,000 |
| Other Current Assets | $126,413,000 | $50,075,000 | $40,449,000 | $35,105,000 |
| Receivables | $254,869,000 | $160,834,000 | $160,045,000 | $121,665,000 |
| Other Receivables | $11,900,000 | $14,900,000 | $12,900,000 | - |
| Taxes Receivable | $7,223,000 | $0 | $3,537,000 | $4,524,000 |
| Accounts Receivable | $235,746,000 | $145,934,000 | $143,608,000 | $117,141,000 |
| Cash Cash Equivalents And Short Term Investments | $261,820,000 | $448,346,000 | $672,296,000 | $757,165,000 |
| Cash And Cash Equivalents | $261,820,000 | $448,346,000 | $672,296,000 | $757,165,000 |
| Prepaid Assets | - | - | $0 | $5,751,000 |
| Restricted Cash | - | - | - | - |
| Debt | ||||
| Net Debt | $226,444,000 | $43,365,000 | - | - |
| Total Debt | $542,806,000 | $543,387,000 | $711,070,000 | $717,024,000 |
| Long Term Debt And Capital Lease Obligation | $533,053,000 | $532,751,000 | $696,106,000 | $705,927,000 |
| Long Term Debt | $483,264,000 | $486,711,000 | $647,703,000 | $651,796,000 |
| Current Debt And Capital Lease Obligation | $9,753,000 | $10,636,000 | $14,964,000 | $11,097,000 |
| Current Debt | $5,000,000 | $5,000,000 | $8,787,000 | $7,029,000 |
| Other Current Borrowings | $5,000,000 | $5,000,000 | $8,787,000 | $7,029,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $787,796,000 | $663,409,000 | $826,842,000 | $789,804,000 |
| Total Non Current Liabilities Net Minority Interest | $541,794,000 | $539,506,000 | $704,283,000 | $713,484,000 |
| Other Non Current Liabilities | $8,741,000 | $6,755,000 | $8,177,000 | $7,557,000 |
| Current Liabilities | $246,002,000 | $123,903,000 | $122,559,000 | $76,320,000 |
| Other Current Liabilities | $130,139,000 | $15,798,000 | - | - |
| Current Deferred Liabilities | $6,705,000 | $6,036,000 | $7,105,000 | $7,879,000 |
| Payables And Accrued Expenses | $99,405,000 | $91,433,000 | $100,490,000 | $57,344,000 |
| Payables | $19,405,000 | $15,594,000 | $36,266,000 | $17,700,000 |
| Total Tax Payable | $0 | $1,457,000 | $0 | - |
| Income Tax Payable | $0 | $1,457,000 | $0 | - |
| Accounts Payable | $19,405,000 | $14,137,000 | $36,266,000 | $17,700,000 |
| Non Current Deferred Liabilities | - | - | - | - |
| Non Current Deferred Taxes Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $616,262,000 | $724,658,000 | $761,958,000 | $814,827,000 |
| Total Equity Gross Minority Interest | $616,262,000 | $724,658,000 | $761,958,000 | $814,827,000 |
| Stockholders Equity | $616,262,000 | $724,658,000 | $761,958,000 | $814,827,000 |
| Retained Earnings | $-1,410,574,000 | $-1,441,013,000 | $-1,457,403,000 | $-1,448,535,000 |
| Other | ||||
| Ordinary Shares Number | $341,052,187 | $382,815,000 | $394,087,000 | $397,025,000 |
| Share Issued | $341,052,187 | $382,815,000 | $394,087,000 | $397,025,000 |
| Tangible Book Value | $-17,412,000 | $137,006,000 | $194,852,000 | $212,773,000 |
| Invested Capital | $1,104,526,000 | $1,216,369,000 | $1,418,448,000 | $1,473,652,000 |
| Working Capital | $397,100,000 | $535,352,000 | $750,231,000 | $843,366,000 |
| Capital Lease Obligations | $54,542,000 | $51,676,000 | $54,580,000 | $58,199,000 |
| Total Capitalization | $1,099,526,000 | $1,211,369,000 | $1,409,661,000 | $1,466,623,000 |
| Additional Paid In Capital | $2,026,802,000 | $2,165,633,000 | $2,219,321,000 | $2,263,322,000 |
| Capital Stock | $34,000 | $38,000 | $40,000 | $40,000 |
| Common Stock | $34,000 | $38,000 | $40,000 | $40,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $49,789,000 | $46,040,000 | $48,403,000 | $54,131,000 |
| Current Deferred Revenue | $6,705,000 | $6,036,000 | $7,105,000 | $7,879,000 |
| Current Capital Lease Obligation | $4,753,000 | $5,636,000 | $6,177,000 | $4,068,000 |
| Current Accrued Expenses | $80,000,000 | $75,839,000 | $64,224,000 | $39,644,000 |
| Goodwill | $430,331,000 | $410,769,000 | $410,769,000 | $412,117,000 |
| Net PPE | $41,076,000 | $40,458,000 | $45,861,000 | $55,726,000 |
| Accumulated Depreciation | $-22,289,000 | $-18,230,000 | $-13,786,000 | $-9,769,000 |
| Gross PPE | $63,365,000 | $58,688,000 | $59,647,000 | $65,495,000 |
| Leases | $16,110,000 | $16,169,000 | $15,998,000 | $16,094,000 |
| Construction In Progress | $3,316,000 | $308,000 | $169,000 | $0 |
| Other Properties | $28,808,000 | $27,794,000 | $29,929,000 | $35,906,000 |
| Machinery Furniture Equipment | $15,131,000 | $14,417,000 | $13,551,000 | $13,495,000 |
| Properties | $0 | $0 | $0 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | $30,401,000 | $20,642,000 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $93,884,000 | $113,545,000 | $82,526,000 | $91,566,000 |
| Operating Activities | ||||
| Operating Cash Flow | $167,904,000 | $183,892,000 | $138,292,000 | $146,780,000 |
| Cash Flow From Continuing Operating Activities | $167,904,000 | $183,892,000 | $138,292,000 | $146,780,000 |
| Operating Gains Losses | $4,409,000 | $2,077,000 | $9,328,000 | $1,165,000 |
| Investing Activities | ||||
| Capital Expenditure | $-74,020,000 | $-70,347,000 | $-55,766,000 | $-55,214,000 |
| Investing Cash Flow | $-119,960,000 | $-70,347,000 | $-55,766,000 | $-210,498,000 |
| Cash Flow From Continuing Investing Activities | $-119,960,000 | $-70,347,000 | $-55,766,000 | $-210,498,000 |
| Net Other Investing Changes | $-2,500,000 | - | - | - |
| Capital Expenditure Reported | $-70,499,000 | $-69,107,000 | $-54,723,000 | $-51,247,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-216,372,000 | $-158,845,000 | $-103,974,000 | $-101,721,000 |
| Financing Cash Flow | $-234,470,000 | $-337,495,000 | $-167,395,000 | $-120,226,000 |
| Cash Flow From Continuing Financing Activities | $-234,470,000 | $-337,495,000 | $-167,395,000 | $-120,226,000 |
| Net Other Financing Charges | $-14,467,000 | $-32,457,000 | $-65,481,000 | $-20,635,000 |
| Net Common Stock Issuance | $-216,372,000 | $-158,845,000 | $-103,974,000 | $-101,721,000 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-5,000,000 | $-639,038,000 | $-5,271,000 | $-7,029,000 |
| Issuance Of Debt | $0 | $472,033,000 | $0 | $0 |
| Interest Paid Supplemental Data | $40,837,000 | $55,099,000 | $48,799,000 | $30,702,000 |
| Income Tax Paid Supplemental Data | $13,127,000 | $23,623,000 | $17,243,000 | $4,356,000 |
| End Cash Position | $261,820,000 | $448,346,000 | $672,296,000 | $757,165,000 |
| Beginning Cash Position | $448,346,000 | $672,296,000 | $757,165,000 | $941,109,000 |
| Changes In Cash | $-186,526,000 | $-223,950,000 | $-84,869,000 | $-183,944,000 |
| Proceeds From Stock Option Exercised | $1,369,000 | $20,812,000 | $7,331,000 | $9,159,000 |
| Common Stock Payments | $-216,372,000 | $-158,845,000 | $-103,974,000 | $-101,721,000 |
| Net Issuance Payments Of Debt | $-5,000,000 | $-167,005,000 | $-5,271,000 | $-7,029,000 |
| Net Long Term Debt Issuance | $-5,000,000 | $-167,005,000 | $-5,271,000 | $-7,029,000 |
| Long Term Debt Payments | $-5,000,000 | $-639,038,000 | $-5,271,000 | $-7,029,000 |
| Long Term Debt Issuance | $0 | $472,033,000 | $0 | $0 |
| Net Business Purchase And Sale | $-43,440,000 | $0 | $0 | $-155,284,000 |
| Purchase Of Business | $-43,440,000 | $0 | $0 | $-171,860,000 |
| Net PPE Purchase And Sale | $-3,521,000 | $-1,240,000 | $-1,043,000 | $-3,967,000 |
| Purchase Of PPE | $-3,521,000 | $-1,240,000 | $-1,043,000 | $-3,967,000 |
| Change In Working Capital | $-56,444,000 | $2,094,000 | $-21,936,000 | $-20,290,000 |
| Change In Other Current Liabilities | $110,058,000 | $4,001,000 | $3,406,000 | $-1,879,000 |
| Change In Other Current Assets | $-75,387,000 | $-7,463,000 | $-15,481,000 | - |
| Change In Payables And Accrued Expense | $5,288,000 | $-5,908,000 | $33,287,000 | $-6,142,000 |
| Change In Accrued Expense | $1,185,000 | $9,911,000 | $21,253,000 | $-5,268,000 |
| Change In Payable | $4,103,000 | $-15,819,000 | $12,034,000 | $-874,000 |
| Change In Account Payable | $4,103,000 | $-15,819,000 | $12,034,000 | $-874,000 |
| Change In Prepaid Assets | $-8,387,000 | $13,790,000 | $-16,681,000 | $-13,644,000 |
| Change In Receivables | $-88,016,000 | $-2,326,000 | $-26,467,000 | $1,375,000 |
| Changes In Account Receivables | $-88,016,000 | $-2,326,000 | $-26,467,000 | $1,375,000 |
| Other Non Cash Items | $7,585,000 | $6,681,000 | $12,842,000 | $24,819,000 |
| Stock Based Compensation | $76,626,000 | $99,026,000 | $104,820,000 | $120,234,000 |
| Deferred Tax | $20,071,000 | $-11,914,000 | $-65,562,000 | $-497,000 |
| Deferred Income Tax | $20,071,000 | $-11,914,000 | $-65,562,000 | $-497,000 |
| Depreciation Amortization Depletion | $85,218,000 | $69,538,000 | $107,668,000 | $54,177,000 |
| Depreciation And Amortization | $85,218,000 | $69,538,000 | $107,668,000 | $54,177,000 |
| Gain Loss On Sale Of PPE | $4,409,000 | $0 | $9,328,000 | $0 |
| Net Income From Continuing Operations | $30,439,000 | $16,390,000 | $-8,868,000 | $-32,828,000 |
| Sale Of Business | - | $0 | $0 | $16,576,000 |
| Gain Loss On Sale Of Business | - | $0 | $0 | $-11,404,000 |
| Amortization Cash Flow | - | - | $102,900,000 | - |
| Amortization Of Intangibles | - | - | $102,900,000 | - |
| Depreciation | - | - | $4,800,000 | - |
| Earnings Losses From Equity Investments | - | - | $4,008,000 | $0 |
Fetched: 2026-06-22